363 related articles for article (PubMed ID: 28204880)
21. Curcumin-C3 Complexed with α-, β-cyclodextrin Exhibits Antibacterial and Antioxidant Properties Suitable for Cancer Treatments.
Reddy DNK; Kumar R; Wang SP; Huang FY
Curr Drug Metab; 2019; 20(12):988-1001. PubMed ID: 31573881
[TBL] [Abstract][Full Text] [Related]
22. Comparative Oral Absorption of Curcumin in a Natural Turmeric Matrix with Two Other Curcumin Formulations: An Open-label Parallel-arm Study.
Gopi S; Jacob J; Varma K; Jude S; Amalraj A; Arundhathy CA; George R; Sreeraj TR; Divya C; Kunnumakkara AB; Stohs SJ
Phytother Res; 2017 Dec; 31(12):1883-1891. PubMed ID: 29027274
[TBL] [Abstract][Full Text] [Related]
23. Safety, Tolerance, and Enhanced Efficacy of a Bioavailable Formulation of Curcumin With Fenugreek Dietary Fiber on Occupational Stress: A Randomized, Double-Blind, Placebo-Controlled Pilot Study.
Pandaran Sudheeran S; Jacob D; Natinga Mulakal J; Gopinathan Nair G; Maliakel A; Maliakel B; Kuttan R; Im K
J Clin Psychopharmacol; 2016 Jun; 36(3):236-43. PubMed ID: 27043120
[TBL] [Abstract][Full Text] [Related]
24. Review: bioavailability and efficacy of 'free' curcuminoids from curcumagalactomannoside (CGM) curcumin formulation.
Matthewman C; Krishnakumar IM; Swick AG
Nutr Res Rev; 2024 Jun; 37(1):14-31. PubMed ID: 36655498
[TBL] [Abstract][Full Text] [Related]
25. The Effect of Formulation of Curcuminoids on Their Metabolism by Human Colonic Microbiota.
Bresciani L; Favari C; Calani L; Francinelli V; Riva A; Petrangolini G; Allegrini P; Mena P; Del Rio D
Molecules; 2020 Feb; 25(4):. PubMed ID: 32093121
[TBL] [Abstract][Full Text] [Related]
26. Bioavailability of a Sustained Release Formulation of Curcumin.
Madhavi D; Kagan D
Integr Med (Encinitas); 2014 Jun; 13(3):24-30. PubMed ID: 26770097
[TBL] [Abstract][Full Text] [Related]
27. Effects of formulation on the bioavailability of lutein and zeaxanthin: a randomized, double-blind, cross-over, comparative, single-dose study in healthy subjects.
Evans M; Beck M; Elliott J; Etheve S; Roberts R; Schalch W
Eur J Nutr; 2013 Jun; 52(4):1381-91. PubMed ID: 23052623
[TBL] [Abstract][Full Text] [Related]
28. Enhanced bioavailability and safety of curcumagalactomannosides as a dietary ingredient.
Liju VB; Jeena K; Kumar D; Maliakel B; Kuttan R; I M K
Food Funct; 2015 Jan; 6(1):276-86. PubMed ID: 25428277
[TBL] [Abstract][Full Text] [Related]
29. Increasing the stability of curcumin in serum with liposomes or hybrid drug-in-cyclodextrin-in-liposome systems: a comparative study.
Matloob AH; Mourtas S; Klepetsanis P; Antimisiaris SG
Int J Pharm; 2014 Dec; 476(1-2):108-15. PubMed ID: 25269006
[TBL] [Abstract][Full Text] [Related]
30. Delivery of curcumin and medicinal effects of the copper(II)-curcumin complexes.
Leung MH; Harada T; Kee TW
Curr Pharm Des; 2013; 19(11):2070-83. PubMed ID: 23116313
[TBL] [Abstract][Full Text] [Related]
31. Curcumin-loaded solid lipid nanoparticles with Brij78 and TPGS improved in vivo oral bioavailability and in situ intestinal absorption of curcumin.
Ji H; Tang J; Li M; Ren J; Zheng N; Wu L
Drug Deliv; 2016; 23(2):459-70. PubMed ID: 24892628
[TBL] [Abstract][Full Text] [Related]
32. Occurrence of orally administered curcuminoid as glucuronide and glucuronide/sulfate conjugates in rat plasma.
Asai A; Miyazawa T
Life Sci; 2000 Oct; 67(23):2785-93. PubMed ID: 11105995
[TBL] [Abstract][Full Text] [Related]
33. Relative bioavailability comparison of different coenzyme Q10 formulations with a novel delivery system.
Liu ZX; Artmann C
Altern Ther Health Med; 2009; 15(2):42-6. PubMed ID: 19284181
[TBL] [Abstract][Full Text] [Related]
34. Brain regional pharmacokinetics following the oral administration of curcumagalactomannosides and its relation to cognitive function.
Kannan RG; Abhilash MB; Dinesh K; Syam DS; Balu M; Sibi I; Krishnakumar IM
Nutr Neurosci; 2022 Sep; 25(9):1928-1939. PubMed ID: 33877014
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and biological assessment of novel N-(hydroxy/methoxy)alkyl β-enaminone curcuminoids.
Theppawong A; De Vreese R; Vannecke L; Grootaert C; Van Camp J; D'hooghe M
Bioorg Med Chem Lett; 2016 Dec; 26(23):5650-5656. PubMed ID: 27843113
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics-Driven Evaluation of the Antioxidant Activity of Curcuminoids and Their Major Reduced Metabolites-A Medicinal Chemistry Approach.
Girst G; Ötvös SB; Fülöp F; Balogh GT; Hunyadi A
Molecules; 2021 Jun; 26(12):. PubMed ID: 34200647
[TBL] [Abstract][Full Text] [Related]
37. The role of turmerones on curcumin transportation and P-glycoprotein activities in intestinal Caco-2 cells.
Yue GG; Cheng SW; Yu H; Xu ZS; Lee JK; Hon PM; Lee MY; Kennelly EJ; Deng G; Yeung SK; Cassileth BR; Fung KP; Leung PC; Lau CB
J Med Food; 2012 Mar; 15(3):242-52. PubMed ID: 22181075
[TBL] [Abstract][Full Text] [Related]
38. Purity Evaluation of Curcuminoids in the Turmeric Extract Obtained by Accelerated Solvent Extraction.
Yadav DK; Sharma K; Dutta A; Kundu A; Awasthi A; Goon A; Banerjee K; Saha S
J AOAC Int; 2017 May; 100(3):586-591. PubMed ID: 28303780
[TBL] [Abstract][Full Text] [Related]
39. Enhancement of curcumin oral absorption and pharmacokinetics of curcuminoids and curcumin metabolites in mice.
Zhongfa L; Chiu M; Wang J; Chen W; Yen W; Fan-Havard P; Yee LD; Chan KK
Cancer Chemother Pharmacol; 2012 Mar; 69(3):679-89. PubMed ID: 21968952
[TBL] [Abstract][Full Text] [Related]
40. Increased bioavailability of curcumin using a novel dispersion technology system (LipiSperse®).
Briskey D; Sax A; Mallard AR; Rao A
Eur J Nutr; 2019 Aug; 58(5):2087-2097. PubMed ID: 29974228
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
